Medicines

Available medicines

Below is a list of our company's marketed medicines. This information is intended only for residents of Australia.

AVONEX® (INTERFERON BETA-1A)

Registered in Australia in October 1999.

For patients: Consumer Medicine Information (CMI)
For healthcare professionals:  Product Information (PI)

FAMPYRA® (FAMPRIDINE)

Registered in Australia in May 2011.

For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)

PLEGRIDY (PEGINTERFERON BETA-1A)

Registered in Australia in November 2014.

For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)

SPINRAZA (NUSINERSEN)

Registered in Australia in November 2017.

For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)

TECFIDERA® (DIMETHYL FUMARATE [DMF])

Registered in Australia in July 2013.

For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)

TYSABRI® (NATALIZUMAB)

Registered in Australia in November 2006.

For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)

VUMERITY® (DIROXIMEL FUMARATE)

Registered in Australia in March 2022.

For patients: Consumer Medicine Information (CMI)
For healthcare professionals: Product Information (PI)

You may also be interested in

<p>Responsibility</p>
Responsibility

Responsibility

<p>About Biogen</p>
Company

About Biogen

<p>Science & Innovation</p>
Company

Science & Innovation